Loading cancer entity…
Loading cancer entity…
Clinical trials
452 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05402124 | The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study | unknown | Phase 2 | 100 | University of CalgaryOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05148143 | RALOX as Second Line Treatment for Advanced Malignant Biliary System Tumor(RALOXBTC) | unknown | Phase 2 | 50 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Dec 8, 2021 |
| clinicaltrials |
Data updated 22 days agoSource updated Jun 2, 2022source: clinicaltrials